the Effect of Integrated Neuomuscular Inhibition Technique on Adult Females With Cervicogenic Headache
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- headache pain intensity
研究概览
简要总结
The purpose of the current study is investigating the effect of integrated neuromuscular inhibition technique on adult females with cervicogenic headache.
Methods: Forty females with cervicogenic headache will be recruited. Patients will be randomly assigned into two groups, group A and group B . Patients in both groups will receive a traditional medical treatment, but group (B) will receive additional integrated neuromuscular inhibition technique.
详细描述
Measurements will be taken for all participants before the start of treatment program then after the end of 4 weeks treatment program, then after another 4 weeks of follow up.all patients will be evaluated for headache pain intensity, cervicogenic headache frequency, cervicogenic headache duration, cervical range of motion in all directions, the isometric endurance capacity of sternocledomastoid and anterior scalene, kinesiophobia, neck disability, and headache impact test-6.
All patients will receive a traditional medical program by an experienced neurologist in the form of Muscle relaxants tizanidine ,4 mg to 32 mg, Three times a day.
Patients in experimental group (B) will receive the same program as control group (A) plus the INIT for upper trapezius and suboccipital muscles. The INIT program will be administrated three times a week for one month.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •1 - A diagnosis of CGH will be made by an experienced neurologist as per the International Classification of Headache Disorders 3rd edition (ICHD-3) , but not including occipital nerve blockage 2-Additional inclusion criteria will include female patients aged> 18 years and<60 years.
- •3-headache intensity ≥ 3 on eleven-point numerical rating scale at enrolment. 4-at least three-month history of headache with a mean frequency of > 1/week. 5-hypomobility of the upper cervical spine (C0 to C3) on manual examination; and reproduction of the headache on palpation of the upper cervical spine (C0 to C3).
- •6-In addition, patients should exhibit active trigger points within the suboccipital, and upper trapezius muscles, ipsilaterally over the symptomatic side reproducing their headache symptoms .
排除标准
- •Patients will be excluded if they have any of the following:
- •cervical radiculopathy,
- •history of neck, shoulder trauma or surgery,
- •history of intervention for head or neck pain within the previous 3 months,
- •A diagnosis of other types of headaches using the criteria of ICHD-3.
研究组 & 干预措施
Control group
All patients will receive a traditional medical program by an experienced neurologist in the form of Muscle relaxants tizanidine ,4 mg to 32 mg, Three times a day.
干预措施: Muscle relaxants tizanidine (Drug)
experimental group
Patients in experimental group (B) will receive the same program as control group (A) plus the INIT for upper trapezius and suboccipital muscles. The INIT program will be administrated three times a week for one month.
干预措施: Muscle relaxants tizanidine (Drug)
experimental group
Patients in experimental group (B) will receive the same program as control group (A) plus the INIT for upper trapezius and suboccipital muscles. The INIT program will be administrated three times a week for one month.
干预措施: integrated neuromuscular inhibition technique (Other)
结局指标
主要结局
headache pain intensity
时间窗: Baseline, 4 weeks and 8 weeks .
headache pain intensity measured by 11-Numerical rating scale. Primary outcome updated to headache intensity to better reflect the study objective.
次要结局
- kinesiophobia(Baseline, 4 weeks and 8 weeks .)
- Isometric endurance capacity of sternocledomastoid and anterior scalene(Baseline, 4 weeks and 8 weeks .)
- the impact of headaches on patients' lives(Baseline, 4 weeks and 8 weeks .)
- neck disability(Baseline, 4 weeks and 8 weeks .)
- headache frequency(Baseline, 4 weeks and 8 weeks)
- headache duration(Baseline, 4 weeks and 8 weeks .)
- cervical ROM in all directions(Baseline, 4 weeks and 8 weeks .)
研究者
Maram Karam Mohammed
Head of the department
Kafrelsheikh University